SCHEMBL7216486

SCHEMBL7216486

COC(=O)C1=Cc2cc(O)ccc2CCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 11/20 0.41
CA9 Q16790 11/20 0.41
CA2 P00918 5/20 0.41
CA1 P00915 3/20 0.41
CA7 P43166 3/20 0.41
CA14 Q9ULX7 3/20 0.41
PDK2 Q15119 2/20 0.41
PDK4 Q16654 2/20 0.41
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
PDK1 Q15118 1/20 0.39
PDK3 Q15120 1/20 0.39
SOD1 P00441 1/20 0.38
MAOA P21397 1/20 0.37
MAOB P27338 1/20 0.37
PRKCI P41743 1/20 0.37
ATM Q13315 1/20 0.36
NLRP3 Q96P20 1/20 0.36
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7218351 0.84 CA12 (0.52) CA12CA9CA2NPC1RAB9A
SCHEMBL5204894 0.84 NR4A2 (0.37) CA12CA9CA2NPC1RAB9A
SCHEMBL7712649 0.82 RAB9A (0.46) CA12CA9NPC1RAB9AL3MBTL1
SCHEMBL7714645 0.81 PNMT (0.40) CA12CA9CA2CA1CA7
SCHEMBL7378104 0.80 CA12 (0.48) CA12CA9NPC1RAB9AL3MBTL1
SCHEMBL5694225 0.79 CA12 (0.44) CA12CA9CA2CA1CA7
SCHEMBL7222844 0.78 MAPT (0.53) NPC1RAB9AL3MBTL1MAOAMAOB
SCHEMBL7222816 0.77 PTGS1 (0.39) CA12CA9CA2NPC1RAB9A
SCHEMBL7222742 0.77 MAOB (0.52) NPC1RAB9AL3MBTL1MAOAMAOB
SCHEMBL7218045 0.77 MAOB (0.55) NPC1RAB9AL3MBTL1MAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6627651-B1 Exhibiting preventive and therapeutic effects against HIV infectious diseases wherein R1 is an optionally substituted five- or six-membered ring group; X1 is a free valency or the like; W is a divalent group and inhibitors of HIV (human TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-09-30 US disclosed
EP-1182195-A1 CYCLIC COMPOUNDS AND USES THEREOF Takeda Chemical Industries, Ltd. (JP) 2002-02-27 EP disclosed